Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Timeliness of MMR vaccination and barriers to vaccination in preschool children.

Jeong YW, Park BH, Kim KH, Han YR, Go UY, Choi WS, Kong KA, Park H.

Epidemiol Infect. 2011 Feb;139(2):247-56. doi: 10.1017/S0950268810000889. Epub 2010 Apr 23.

PMID:
20412613
2.

Why do parents hesitate to vaccinate their children against measles, mumps and rubella?

Alfredsson R, Svensson E, Trollfors B, Borres MP.

Acta Paediatr. 2004 Sep;93(9):1232-7.

PMID:
15384890
3.

Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.

Hu Y, Li Q, Luo S, Lou L, Qi X, Xie S.

PLoS One. 2013 Aug 27;8(8):e73264. doi: 10.1371/journal.pone.0073264. eCollection 2013.

4.

Timeliness of MMR vaccination--influence on vaccination coverage.

Dannetun E, Tegnell A, Hermansson G, Törner A, Giesecke J.

Vaccine. 2004 Oct 22;22(31-32):4228-32.

PMID:
15474712
5.

[Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].

Rotily M, Guagliardo V, Fontaine D, Garros B, Mayer C, Arrighi J, Woronoff AS, Ledesert B, Lepec R, Chabaud F, Janvrin MP, Baudier F.

Rev Epidemiol Sante Publique. 2001 Sep;49(4):331-41. French.

PMID:
11567200
6.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
8.

Measles vaccination coverage among five-year-old children: implications for disease elimination in Australia.

Lawrence GL, MacIntyre CR, Hull BP, McIntyre PB.

Aust N Z J Public Health. 2003;27(4):413-8.

PMID:
14705304
9.

Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.

Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW.

Clin Infect Dis. 2006 Feb 1;42(3):315-9. Epub 2005 Dec 15.

PMID:
16392073
10.

Measles, mumps and rubella: control by vaccination.

van Druten JA, de Boo T, Plantinga AD.

Dev Biol Stand. 1986;65:53-63.

PMID:
3556777
11.

Follow-up of MMR vaccination status in children referred to a pediatric immunization clinic on account of egg allergy.

Goodyear-Smith F, Wong F, Petousis-Harris H, Wilson E, Turner N.

Hum Vaccin. 2005 May-Jun;1(3):118-22. Epub 2005 May 31.

PMID:
17012862
12.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100
13.

Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?

Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.

East Mediterr Health J. 2009 Jan-Feb;15(1):85-93.

PMID:
19469430
14.

[The knowledge about measles, mumps and rubella among parents in the county of Roskilde].

Hansen LF.

Ugeskr Laeger. 2002 Dec 2;164(49):5748-52. Danish.

PMID:
12523211
15.

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.

Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, Litton P, Miller E.

Vaccine. 2002 Jan 15;20(7-8):1134-40.

PMID:
11803074
17.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
18.

Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.

Mrozek-Budzyn D, Kiełtyka A, Majewska R.

Pediatr Infect Dis J. 2010 May;29(5):397-400. doi: 10.1097/INF.0b013e3181c40a8a.

PMID:
19952979
19.

Serosurvey of measles, mumps and rubella antibodies in Saudi children.

Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.

Saudi Med J. 2005 Oct;26(10):1551-4.

PMID:
16228054
20.

Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.

Brown KF, Shanley R, Cowley NA, van Wijgerden J, Toff P, Falconer M, Ramsay M, Hudson MJ, Green J, Vincent CA, Kroll JS, Fraser G, Sevdalis N.

Vaccine. 2011 Feb 11;29(8):1700-9. doi: 10.1016/j.vaccine.2010.12.030. Epub 2010 Dec 24.

PMID:
21185850

Supplemental Content

Support Center